George A. Xixis
Keine laufenden Positionen mehr
Karriereverlauf von George A. Xixis
Ehemalige bekannte Positionen von George A. Xixis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMDeC Foundation, Inc. | Corporate Officer/Principal | 30.01.2003 | 30.01.2003 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - | - |
Boston Harbor Angels, Inc.
 Boston Harbor Angels, Inc. Investment ManagersFinance Boston Harbor Angels Inc (Boston Harbor Angels) is a venture capital firm founded by Michael Williams in 2004. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 09.10.2009 | - |
Ausbildung von George A. Xixis
| Massachusetts Institute of Technology | Undergraduate Degree |
| New York University | Graduate Degree |
| Brooklyn Law School | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Private Equity Investor | 1 |
Sektoral
| Finance | 3 |
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Boston Harbor Angels, Inc.
Boston Harbor Angels, Inc. Investment ManagersFinance Boston Harbor Angels Inc (Boston Harbor Angels) is a venture capital firm founded by Michael Williams in 2004. The firm is headquartered in Boston, Massachusetts. | Finance |
| AMDeC Foundation, Inc. | |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
- Börse
- Insiders
- George A. Xixis
- Erfahrung